Biopharmaceutical drugs are revolutionizing medicine, but at a cost. Almost without exception, they're more expensive than small-molecule drugs, but they also are playing an increasing role in patient care. Pfizer's Dr. Robert Popovian informs us about the need to consider the value of these drugs – not just their price.
Biopharmaceutical drugs are revolutionizing medicine, but at a cost. Almost without exception, they're more expensive than small-molecule drugs, but they also are playing an increasing role in patient care. Pfizer's Dr. Robert Popovian informs us about the need to consider the value of these drugs – not just their price.